Thermo Fisher Scientific Elects New Director to Board

Rhea-AI Summary

Thermo Fisher Scientific (NYSE:TMO) has announced the election of Karen S. Lynch to its board of directors, effective February 19, 2025. This appointment increases the board's size to 12 members. Lynch, the former president and CEO of CVS Health , brings over three decades of healthcare industry experience. During her tenure at CVS Health, she led more than 300,000 employees and oversaw operations reaching over 120 million consumers through healthcare benefits, pharmacy benefits management, and 9,000+ community health locations.

Lynch's extensive career includes executive positions at Aetna, Magellan Health Services, and Cigna She began her career as a CPA at Ernst & Young LLP and has served on the boards of CVS Health and U.S. Bancorp.

Positive

• Addition of experienced healthcare executive with proven leadership in managing large-scale operations
• Strategic board expansion bringing expertise in healthcare benefits and pharmacy management
• Enhanced governance through appointment of former CEO of major healthcare

Negative

• None.

WALTHAM, Mass.--(BUSINESS WIRE)-- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced Karen S. Lynch has been elected to its board of directors, effective February 19, 2025. The appointment brings the total number of Thermo Fisher board members to 12.

Ms. Lynch is a seasoned health care executive with over three decades of experience in the industry. As the former president and chief executive officer of CVS Health Corporation (NYSE: CVS), a leading health solutions company, she was responsible for leading more than 300,000 employees. Under Ms. Lynch’s leadership, CVS Health touched the lives of more than 120 million consumers through its health care benefits and pharmacy benefits management businesses, and presence in over 9,000 community health destinations across the U.S. Prior to her service as president and CEO of CVS Health, Ms. Lynch served as an Executive Vice President of CVS Health and President of Aetna, and prior to that, Ms. Lynch held a number of executive positions at Aetna Inc., a health insurance company, Magellan Health Services, a health care management company, and at Cigna Corporation, a global health insurance company. Ms. Lynch began her career as a Certified Public Accountant at the auditing firm Ernst & Young LLP, and has previously served as a board member of CVS Health and U.S. Bancorp.

"We are extremely pleased to have Karen join the board," said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher Scientific. "Her knowledge and insight will be an incredible asset as we continue to scale our company and deliver for our stakeholders."

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250219315440/en/

Media Contact Information:

Sandy Pound

Phone: 781-622-1223

E-mail: sandy.pound@thermofisher.com

Investor Contact Information:

Rafael Tejada

Phone: 781-622-1356

E-mail: rafael.tejada@thermofisher.com

Source: Thermo Fisher Scientific Inc.

FAQ

When will Karen Lynch join Thermo Fisher Scientific's (TMO) board of directors?

Karen Lynch will join Thermo Fisher Scientific's board of directors effective February 19, 2025.

How many members will be on TMO's board after Karen Lynch's appointment?

After Karen Lynch's appointment, Thermo Fisher Scientific's board will have 12 members.

What was Karen Lynch's most recent executive position before joining TMO's board?

Karen Lynch was the president and chief executive officer of CVS Health

What relevant industry experience does Karen Lynch bring to TMO's board?

Karen Lynch brings over three decades of healthcare industry experience, including executive positions at CVS Health, Aetna, Magellan Health Services, and Cigna

How many employees did Karen Lynch oversee as CEO of CVS Health?

As CEO of CVS Health, Karen Lynch was responsible for leading more than 300,000 employees.